LLY compared with RPRX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

RPRXRoyalty Pharma plc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

RPRXRoyalty Pharma plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

RPRX

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±5.5%▲+1.75%×0.33

Q2 FY26±5.4%▲+0.47%×0.09

= impliedLLY realized, solidRPRX realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26—▲+0.56%—

Feb 11 '26—▲+0.09%—

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,353.49· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

RPRXRoyalty Pharma plc

67.29▼−0.42%· post 67.29· delayed

After hoursNov 6 '26delayed

Mkt cap$38.8BRevenue$690MQ3 FY26Revenue$2.4BFY25

Compare

After hoursNov 6 '26delayed

LLYELI Lilly & Co

RPRXRoyalty Pharma plc

1,360.90▼−0.28%post 1,353.49delayed

Price

67.29▼−0.42%post 67.29delayed

$1.2T

Mkt cap

$38.8B

Q3 FY26$24.4B

Revenue

$690MQ3 FY26

FY25$65.2B

Revenue

$2.4BFY25

LLY1,360.90▼−0.28%vsRPRX67.29▼−0.42%After hoursNov 6 '26delayed